Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Richard A. Miller,M.D.$72.6M
Market Cap • 25/04/20242014
(há 10 anos)
2016
(8 years ago)
NASDAQ
Listagem
Burlingame
Sede • California29
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CRVSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.